PHARMAVEST ApS — Credit Rating and Financial Key Figures
CVR number: 26385180
Naverland 22, 2600 Glostrup
tel: 70251117
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 159.05 | 1 761.84 | 1 770.66 | 1 975.24 | 1 925.93 |
| Employee benefit expenses | - 612.19 | - 691.92 | - 690.89 | - 818.93 | -1 300.74 |
| Other operating expenses | - 280.63 | ||||
| Total depreciation | -82.65 | -78.24 | -45.28 | -42.62 | - 125.56 |
| EBIT | 464.21 | 991.68 | 1 034.48 | 1 113.68 | 219.00 |
| Other financial income | 2.11 | 14.96 | 15.43 | 89.83 | 167.97 |
| Other financial expenses | -24.88 | -24.63 | - 170.08 | -6.28 | -35.17 |
| Reduction non-current investment assets | 90.08 | ||||
| Net income from associates (fin.) | -57.69 | - 144.40 | |||
| Pre-tax profit | 383.75 | 837.60 | 879.83 | 1 287.32 | 351.80 |
| Income taxes | - 102.49 | - 219.65 | - 199.37 | - 273.93 | -80.57 |
| Net earnings | 281.26 | 617.95 | 680.46 | 1 013.39 | 271.22 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 148.73 | 160.67 | 19.80 | 615.19 | 9.00 |
| Tangible assets total | 148.73 | 160.67 | 19.80 | 615.19 | 9.00 |
| Holdings in group member companies | 54.32 | ||||
| Other receivables | 30.00 | 30.00 | 30.56 | ||
| Investments total | 54.32 | 30.00 | 30.00 | 30.56 | |
| Long term receivables total | |||||
| Finished products/goods | 1 835.17 | 1 167.85 | 1 210.31 | 1 526.26 | 1 533.07 |
| Inventories total | 1 835.17 | 1 167.85 | 1 210.31 | 1 526.26 | 1 533.07 |
| Current trade debtors | 1 088.12 | 910.00 | 650.54 | 951.87 | 1 181.59 |
| Current amounts owed by group member comp. | 142.54 | 59.34 | 92.12 | 114.68 | |
| Prepayments and accrued income | 0.11 | 0.12 | 35.13 | 0.14 | |
| Current other receivables | 22.99 | 41.91 | 131.39 | ||
| Current deferred tax assets | 5.40 | 8.30 | 32.60 | ||
| Short term receivables total | 1 236.17 | 1 000.75 | 819.71 | 1 198.08 | 1 214.19 |
| Other current investments | 613.42 | 1 352.55 | 2 102.99 | 2 205.59 | |
| Cash and bank deposits | 1 917.15 | 2 349.85 | 2 609.23 | 1 365.07 | 2 106.80 |
| Cash and cash equivalents | 1 917.15 | 2 963.27 | 3 961.79 | 3 468.05 | 4 312.39 |
| Balance sheet total (assets) | 5 191.54 | 5 292.53 | 6 041.60 | 6 837.58 | 7 099.22 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Shares repurchased | 120.00 | 125.00 | 125.00 | 500.00 | 1 000.00 |
| Retained earnings | 2 902.52 | 3 058.78 | 3 551.73 | 3 732.19 | 3 745.58 |
| Profit of the financial year | 281.26 | 617.95 | 680.46 | 1 013.39 | 271.22 |
| Shareholders equity total | 3 803.78 | 4 301.73 | 4 857.19 | 5 745.58 | 5 516.80 |
| Provisions | 32.47 | 46.71 | |||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 5.20 | 12.57 | 16.29 | 30.14 | 5.44 |
| Current trade creditors | 441.10 | 215.98 | 580.33 | 452.20 | 1 039.61 |
| Current owed to group member | 5.84 | ||||
| Short-term deferred tax liabilities | 107.89 | 222.55 | 155.21 | 249.94 | 153.35 |
| Other non-interest bearing current liabilities | 833.57 | 539.70 | 400.12 | 313.00 | 378.18 |
| Current liabilities total | 1 387.76 | 990.80 | 1 151.94 | 1 045.29 | 1 582.41 |
| Balance sheet total (liabilities) | 5 191.54 | 5 292.53 | 6 041.60 | 6 837.58 | 7 099.22 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.